SNY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Sanofi SA's research and development for the six months ended in Jun. 2016 was $2,825 Mil. Its research and development for the trailing twelve months (TTM) ended in Jun. 2016 was $5,536 Mil.
This is the expense the company spent on research and development.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sanofi SA Research & Development for the trailing twelve months (TTM) ended in Jun. 2016 was $5,536 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Sanofi SA Annual Data
|Research & Development||5,852||6,604||6,182||6,681||6,015||6,300||6,437||6,317||5,755||5,536|
Sanofi SA Semi-Annual Data
|Research & Development||3,278||3,020||3,278||3,090||3,104||3,162||2,885||2,699||2,916||2,825|